NDC 13668-0342-30
LAMOTRIGINE ER TABS 200 MG 30CT
Available — 2-Day Shipping
NDC
13668-0342-30
Generic Name
—
Brand Name
—
Strength
—
Dosage Form
—
Route
—
Package Size
—
Labeler
—
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Lamotrigine extended-release tablets are indicated for: adjunctive therapy for primary generalized tonic-clonic seizures (PGTC) and partial-onset seizures with or without secondary generalization in patients aged 13 years and older. ( 1.1 ) conversion to monotherapy in patients aged 13 years and older with partial-onset seizures who are receiving treatment with a single antiepileptic drug (AED). ( 1.2 ) Limitation of use: Safety and effectiveness in patients younger than…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 13668-0342-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).